MK

Manish Khandelwal

Active Director Designated Partner DIN 07441892
DIN 07441892 First appointment Apr 2016 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2016
Shareholding value β€’β€’β€’β€’ Premium profile

About Manish Khandelwal

Data last updated:

Manish Khandelwal is a Designated Partner at Curegen Lifescience Llp (since 2016). The company operates in Business Services.

DIN 07441892
Primary Designation Designated Partner
Industry Business Services
First Appointment 08 Apr 2016
Oldest Company Age 10 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner08 Apr 20162016Active

Board colleagues of Manish Khandelwal

NameDINCompanyDesignation
Ankit Khandelwal08300007Curegen Lifescience LlpDesignated Partner
Punit Kumar Khandelwal07439913Curegen Lifescience LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Curegen Lifescience Llp
Premium access

Shareholding and investment profile for Manish Khandelwal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Manish Khandelwal

Manish Khandelwal currently holds 1 directorship: Curegen Lifescience Llp (Designated Partner, since 08 Apr 2016).

Manish Khandelwal was first appointed on 08 Apr 2016 as Designated Partner at Curegen Lifescience Llp.

The current boards of Manish Khandelwal's companies include Ankit Khandelwal (Curegen Lifescience Llp), Punit Kumar Khandelwal (Curegen Lifescience Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available